Tim Kaine actually said...

"I think we have been too aggressive--too aggressive on pricing."

"the challenges associated with developing treatments and the investments we make to develop novel medicines, that is really completely a red herring with respect to Syprine."

"When did that realization strike you that you were basically making a drug that some people needed to stay alive?"

"The last time I was in China talking at great length about the South China Sea with our counterparts, I said that we are in the ironic situation where the United States has not ratified the Law of the..."